secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001826667-25-000077
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus launches exchange offer for Series A Preferred, up to 11.9M common shares
--------------------------------------------------------------------------------

- Offers up to 11,860,206 common shares in exchange for each share of Series A Convertible Preferred at $4.00 per share based on liquidation preference plus accrued dividends through Aug 10, 2027.
- Consent solicitation seeks amendment to automatically convert remaining Preferred after offer closes at a ratio 11.3% lower than exchange offer.
- Holders representing ~55% of outstanding Preferred have agreed to tender and consent via Tender and Support Agreements.
- Expiration date: 12:01 a.m. ET on July 23, 2025; shares can be withdrawn anytime before.
- 3,594,002 Preferred shares outstanding as of June 13, 2025; Preferred stock not publicly traded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000077/0001826667-25-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000077/tlsi-20250623.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer